Atria Investments’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$683K Sell
3,253
-2,289
-41% -$575K 0.01% 1282
2025
Q4
$1.58M Sell
5,542
-440
-7% -$138K 0.02% 840
2025
Q3
$1.85M Sell
5,982
-259
-4% -$81.1K 0.02% 757
2025
Q2
$1.96M Sell
6,241
-262
-4% -$75.6K 0.02% 734
2025
Q1
$1.71M Buy
6,503
+468
+8% +$127K 0.02% 769
2024
Q4
$1.58M Buy
6,035
+502
+9% +$126K 0.02% 784
2024
Q3
$1.29M Sell
5,533
-330
-6% -$67.8K 0.02% 856
2024
Q2
$1.18M Buy
+5,863
New +$1.06M 0.02% 851
2023
Q3
Sell
-3,716
Closed -$1.07M 879
2023
Q2
$1.07M Buy
3,716
+85
+2% +$25.8K 0.02% 800
2023
Q1
$1.16M Sell
3,631
-105
-3% -$31.1K 0.02% 753
2022
Q4
$1.1M Buy
+3,736
New +$1.03M 0.02% 729
2022
Q2
Sell
-4,142
Closed -$1.1M 848
2022
Q1
$1.1M Buy
+4,142
New +$1.02M 0.02% 811
2020
Q2
Sell
-1,256
Closed -$208K 707
2020
Q1
$208K Sell
1,256
-872
-41% -$159K 0.02% 522
2019
Q4
$364K Sell
2,128
-48
-2% -$8K 0.01% 905
2019
Q3
$359K Buy
2,176
+68
+3% +$9.56K 0.01% 662
2019
Q2
$316K Buy
+2,108
New +$216K 0.01% 724

Other funds holding PODD

Atria Investments's PODD Position: Q1 2026 in Review

Atria Investments reduced its Insulet (PODD) stake by 41% in Q1 2026, selling an estimated $575K and leaving 3,253 shares worth $683K. The position accounts for 0.01% of the portfolio, ranked #1282.

Atria Investments first reported a position in PODD in Q2 2019 and has held it in 16 quarters since. The position peaked at $1.96M in Q2 2025. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • Atria Investments held 3,253 shares of Insulet worth $683K as of Q1 2026.
  • Atria Investments sold 2,289 Insulet shares in Q1 2026, an estimated $575K.
  • Insulet made up 0.01% of Atria Investments's portfolio in Q1 2026, its #1282 holding.
  • Atria Investments first reported a position in Insulet in Q2 2019 and has held it in 16 quarters since.
  • Atria Investments's Insulet position peaked at $1.96M in Q2 2025.
  • 784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Atria Investments's 13F filing for Q1 2026, filed 5 May 2026.